341 related articles for article (PubMed ID: 30193081)
21. Zinc deficiency in patients with chronic pancreatitis.
Vujasinovic M; Hedström A; Maisonneuve P; Valente R; von Horn H; Löhr JM; Haas SL
World J Gastroenterol; 2019 Feb; 25(5):600-607. PubMed ID: 30774274
[TBL] [Abstract][Full Text] [Related]
22. The use of pancreatic enzyme replacement therapy in patients with a diagnosis of chronic pancreatitis and pancreatic cancer in the US is infrequent and inconsistent.
Forsmark CE; Tang G; Xu H; Tuft M; Hughes SJ; Yadav D
Aliment Pharmacol Ther; 2020 May; 51(10):958-967. PubMed ID: 32249970
[TBL] [Abstract][Full Text] [Related]
23. Exocrine Pancreatic Insufficiency Dosing Guidelines for Pancreatic Enzyme Replacement Therapy Vary Widely Across Disease Types.
Lewis DM; Rieke JG; Almusaylim K; Kanchibhatla A; Blanchette JE; Lewis C
Dig Dis Sci; 2024 Feb; 69(2):615-633. PubMed ID: 38117426
[TBL] [Abstract][Full Text] [Related]
24. A 6-month, open-label clinical trial of pancrelipase delayed-release capsules (Creon) in patients with exocrine pancreatic insufficiency due to chronic pancreatitis or pancreatic surgery.
Gubergrits N; Malecka-Panas E; Lehman GA; Vasileva G; Shen Y; Sander-Struckmeier S; Caras S; Whitcomb DC
Aliment Pharmacol Ther; 2011 May; 33(10):1152-61. PubMed ID: 21418260
[TBL] [Abstract][Full Text] [Related]
25. Cost-effectiveness analysis of pancreatin minimicrospheres in patients with pancreatic exocrine insufficiency due to chronic pancreatitis.
Morawski JH; Prüfert A; van Engen A; Foerster D; Sander-Struckmeier S; Małecka-Panas E; Pezzilli R
J Med Econ; 2012; 15 Suppl 1():15-25. PubMed ID: 23043594
[TBL] [Abstract][Full Text] [Related]
26. Dependence of PERT endpoint on endogenous lipase activity.
Gao WY; Mulberg AE
Pancreas; 2014 Nov; 43(8):1232-8. PubMed ID: 25102439
[TBL] [Abstract][Full Text] [Related]
27. Pancreatic Enzyme Replacement Therapy in Patients with Non-pancreatic Digestive Conditions: A Nationwide Claims Analysis.
Phillips AE; Tang G; Wang X; Forsmark CE; Yadav D
Dig Dis Sci; 2023 May; 68(5):1754-1761. PubMed ID: 36370243
[TBL] [Abstract][Full Text] [Related]
28. Effect of Pancrelipase Therapy on Exocrine Pancreatic Insufficiency Symptoms and Coefficient of Fat Absorption Associated With Chronic Pancreatitis.
Barkin JA; Barkin JS
Pancreas; 2021 Feb; 50(2):176-182. PubMed ID: 33560089
[TBL] [Abstract][Full Text] [Related]
29. Staging exocrine pancreatic dysfunction.
Khan A; Vege SS; Dudeja V; Chari ST
Pancreatology; 2022 Jan; 22(1):168-172. PubMed ID: 34916141
[TBL] [Abstract][Full Text] [Related]
30. Pancreatic Exocrine Insufficiency as a Complication of Gastrointestinal Surgery and the Impact of Pancreatic Enzyme Replacement Therapy.
Chaudhary A; Domínguez-Muñoz JE; Layer P; Lerch MM
Dig Dis; 2020; 38(1):53-68. PubMed ID: 31422398
[TBL] [Abstract][Full Text] [Related]
31. Romanian guidelines on the diagnosis and treatment of exocrine pancreatic insufficiency.
Gheorghe C; Seicean A; Saftoiu A; Tantau M; Dumitru E; Jinga M; Negreanu L; Mateescu B; Gheorghe L; Ciocirlan M; Cijevschi C; Constantinescu G; Dima S; Diculescu M;
J Gastrointestin Liver Dis; 2015 Mar; 24(1):117-23. PubMed ID: 25822444
[TBL] [Abstract][Full Text] [Related]
32. Fecal Fat Analyses in Chronic Pancreatitis Importance of Fat Ingestion before Stool Collection.
Erchinger F; Engjom T; Jurmy P; Tjora E; Gilja OH; Dimcevski G
PLoS One; 2017; 12(1):e0169993. PubMed ID: 28095460
[TBL] [Abstract][Full Text] [Related]
33. CREON (Pancrelipase Delayed-Release Capsules) for the treatment of exocrine pancreatic insufficiency.
Kuhn RJ; Gelrud A; Munck A; Caras S
Adv Ther; 2010 Dec; 27(12):895-916. PubMed ID: 21086085
[TBL] [Abstract][Full Text] [Related]
34. Provider Differences in Monitoring and Management of Exocrine Pancreatic Insufficiency in Chronic Pancreatitis.
Srivoleti P; Dolan RD; Yang AL; Jin DX; Banks PA; McNabb-Baltar J
Pancreas; 2022 Jan; 51(1):25-27. PubMed ID: 35195591
[TBL] [Abstract][Full Text] [Related]
35. Efficacy of lower than standard doses of pancreatic enzyme supplementation therapy during acid inhibition in patients with pancreatic exocrine insufficiency.
Vecht J; Symersky T; Lamers CB; Masclee AA
J Clin Gastroenterol; 2006 Sep; 40(8):721-5. PubMed ID: 16940886
[TBL] [Abstract][Full Text] [Related]
36. [Chronic pancreatitis: analysis of disease progression factors].
Diéguez C; Jiménez C; Martín JL; Prados JC; González AR; Caba O
Rev Med Chil; 2022 Dec; 150(12):1555-1564. PubMed ID: 37906776
[TBL] [Abstract][Full Text] [Related]
37. Meal patterns, dietary fat intake and pancreatic enzyme use in preadolescent children with cystic fibrosis.
Schall JI; Bentley T; Stallings VA
J Pediatr Gastroenterol Nutr; 2006 Nov; 43(5):651-9. PubMed ID: 17130744
[TBL] [Abstract][Full Text] [Related]
38. Exocrine Pancreas Dysfunction in Type 1 Diabetes.
Foster TP; Bruggeman B; Campbell-Thompson M; Atkinson MA; Haller MJ; Schatz DA
Endocr Pract; 2020 Dec; 26(12):1505-1513. PubMed ID: 33471743
[TBL] [Abstract][Full Text] [Related]
39. Patients with exocrine insufficiency due to chronic pancreatitis are undertreated: a Dutch national survey.
Sikkens EC; Cahen DL; van Eijck C; Kuipers EJ; Bruno MJ
Pancreatology; 2012; 12(1):71-3. PubMed ID: 22487479
[TBL] [Abstract][Full Text] [Related]
40. Efficacy and tolerability of a new formulation of pancrelipase delayed-release capsules in children aged 7 to 11 years with exocrine pancreatic insufficiency and cystic fibrosis: a multicenter, randomized, double-blind, placebo-controlled, two-period crossover, superiority study.
Graff GR; Maguiness K; McNamara J; Morton R; Boyd D; Beckmann K; Bennett D
Clin Ther; 2010 Jan; 32(1):89-103. PubMed ID: 20171415
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
